Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of cancers with acquired resistance to kit inhibitors

Treatment of cancers with acquired resistance to kit inhibitors

US Patent 8680124 · Granted Mar 25, 2014

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Diaryl ureas for diseases mediated by PDGFR2014
Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevent2014
Methods for prognosis and monitoring cancer therapy2012
Regulation of human transmembrane serine protease2009
Fused tricyclic heterocycles useful for treating hyper-proliferative disorders2008
Regulation of human transmembrane serine protease2008
Fused tricyclic heterocycles useful for treating hyper-proliferative disorders2006
Regulation of human transmembrane serine protease2004
Substituted 5-biarylpentanoic acids and derivatives as matrix metalloprotease in2000
Substituted cycloalkanecarboxylic acid derivatives as matrix metalloprotease inh1999
Substituted 4-biarylbutyric acid derivatives as matrix metalloprotease inhibitor1999
Substituted cycloalkanecarboxylic acid derivatives as matrix metalloprotease inh1999